<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=152245"><dc:title>Conjugates of monocyclic β-lactams and siderophore mimetics</dc:title><dc:creator>Krajnc,	Alen	(Avtor)
	</dc:creator><dc:creator>Gobec,	Stanislav	(Avtor)
	</dc:creator><dc:subject>antimicrobial resistance</dc:subject><dc:subject>conjugates</dc:subject><dc:subject>aztreonam</dc:subject><dc:subject>anticoagulant</dc:subject><dc:subject>β-lactams</dc:subject><dc:subject>monocyclic β-lactams</dc:subject><dc:subject>siderophores</dc:subject><dc:description>Introduction: β-Lactams, which include monobactams, remain the most important class of antibiotics worldwide. Aztreonam, the only monobactam in clinical use, has remarkable activity against many Gram-negative bacteria, but limited activity against some of the most problematic multidrug-resistant (MDR) pathogens, such as MDR Pseudomonas aeruginosa and Acinetobacter baumannii co-expressing extended-spectrum- and metallo-β-lactamases, which can inactivate aztreonam by hydrolysis. 
Areas covered: Structurally novel siderophore-conjugated aztreonam derivatives with improved antibacterial properties against several high-priority pathogens are claimed. This invention reports that sidechain extension of aztreonam is tolerated; the coupling of its aminothiazoloxime carboxylic acid part with a siderophore mimetic significantly improved the antibacterial activity against several problematic strains, including MDR A. baumannii isolates with carbapenemase/cephalosporinase activity. 
Expert Opinion: Finding new strategies to tackle bacterial resistance to β-lactam antibiotics is critical. Considering that β lactams are validated and safe drugs, this research may stimulate the field to develop new ideas in the arena of antimicrobial drug discovery, particularly with respect to siderophore mimetics.</dc:description><dc:date>2023</dc:date><dc:date>2023-11-14 12:02:45</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>152245</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
